Related Experiment Video
Updated: Aug 29, 2025

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Progression of ulcerative colitis following diversion colitis
Katsuki Yaguchi1,2, Yusuke Matsune1, Reiko Kunisaki3,4
1Inflammatory Bowel Disease Center, Yokohama City University Medical Center, 4-57 Urafune-cho Minami-ku, Yokohama, 232-0024, Japan.
A rare case shows diversion colitis may trigger ulcerative colitis (UC) development. This highlights potential immune responses in the gut following surgical diversions.
Area of Science:
- Gastroenterology
- Colorectal Surgery
- Immunology
Background:
- Diversion colitis and ulcerative colitis (UC) are distinct inflammatory bowel conditions.
- Several case reports suggest a potential link between diversion colitis and the subsequent development of UC.
Observation:
- A 63-year-old male developed diversion colitis in a surgically created blind sigmoid colon segment after Hartmann's operation.
- Following stoma closure, symptoms of bloody stools (hematochezia) initially improved with topical mesalazine but recurred.
- Colonoscopy revealed characteristic inflammation in both the rectal and blind sigmoid colon segments.
Findings:
- Histological examination of the affected colon segments showed basal plasmacytosis, goblet cell depletion, and cryptitis.
- These findings are histologically characteristic of ulcerative colitis (UC).
- This represents the fourth reported case of UC developing subsequent to diversion colitis.
Implications:
- The study suggests that local inflammation from diversion colitis may trigger the development of UC.
- Potential mechanisms include hematogenous or lymphogenous spread of lymphocytes or autoantibodies.
- This case underscores the importance of monitoring for UC development in patients with a history of diversion colitis.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD

